AI Analysis

How does PARD make money? Does PARD have pricing power? What's the Earnings Whisper? Will PARD profit more as the business scales? What is PARD's management track record? Is PARD's current price justified?

Poniard Pharmaceuticals, Inc.

$0 +$0.00 (+0.00%)

OTC · 14 Sep 2026 20:00 UTC

Previous Close

Day Range

$0 - $0

Year Range

$0$0

Market Cap

150

AVG Volume

Trailing/Forward PE

-0/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (USD) · TTM

PARD Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
11 Q3	0
11 Q2	0
11 Q1	0
10 Q4	0
10 Q3	0
10 Q2	0
10 Q1	0
09 Q4	0
09 Q3	0
09 Q2	0

Net Income (USD) · TTM

PARD Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
11 Q3	-16.04M
11 Q2	-18.72M
11 Q1	-21.41M
10 Q4	-30.05M
10 Q3	-38.05M
10 Q2	-41.48M
10 Q1	-44.65M
09 Q4	-45.72M
09 Q3	-46.49M
09 Q2	-48.85M

Operating Income (USD) · TTM

PARD Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
11 Q3	-15.53M
11 Q2	-17.74M
11 Q1	-19.87M
10 Q4	-27.96M
10 Q3	-35.69M
10 Q2	-38.94M
10 Q1	-42.05M
09 Q4	-42.98M
09 Q3	-43.89M
09 Q2	-47.1M

EBITDA (USD) · TTM

PARD EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
11 Q3	-14.26M
11 Q2	-16.45M
11 Q1	-18.57M
10 Q4	-25.02M
10 Q3	-31.25M
10 Q2	-34.47M
10 Q1	-37.54M
09 Q4	-38.97M
09 Q3	-41.34M
09 Q2	-44.45M

Cash Flows (USD) · TTM

PARD Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
11 Q3	-10.47M
11 Q2	-12.64M
11 Q1	-17.97M
10 Q4	-24.28M
10 Q3	-27.72M
10 Q2	-32.06M
10 Q1	-32.79M
09 Q4	-35.51M
09 Q3	-36.34M
09 Q2	-37.3M

EPS (USD) · TTM

PARD EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
11 Q3	-11.69
11 Q2	-14.49
11 Q1	-17.29
10 Q4	-26.49
10 Q3	-35.82
10 Q2	-42.22
10 Q1	-47.82
09 Q4	-51.42
09 Q3	-54.08
09 Q2	-56.88

Expenses (USD) · TTM

PARD Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
11 Q3	14.32M
11 Q2	16.53M
11 Q1	18.66M
10 Q4	25.11M
10 Q3	32.58M
10 Q2	35.83M
10 Q1	38.95M
09 Q4	40.46M
09 Q3	42.9M
09 Q2	46.24M

Shares Outstanding (USD) · TTM

PARD Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
11 Q3	-3.95M
11 Q2	-4.87M
11 Q1	-6.1M
10 Q4	-8.81M
10 Q3	-9.7M
10 Q2	-10.06M
10 Q1	-9.46M
09 Q4	-7.04M
09 Q3	-4.71M
09 Q2	-2.78M

PE Ratio

PARD PE Ratio by quarter
Period	PE Ratio
Mar 04	30.57
Mar 04	27.51
Mar 04	27.16
Mar 04	31.34
Feb 04	31.2
Feb 04	37.4
Feb 04	37.68
Feb 04	33.22
Jan 04	33.01
Jan 04	33.57
Jan 04	33.98
Jan 04	31.34
Jan 04	29.6

Free Cash Flow Yield

PARD Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-6985017.06%
Sep 26	-6985016.85%
Aug 26	-6985017.06%
Aug 26	-6985017.06%
Aug 26	-6985017.06%
Aug 26	-6985017.06%
Jul 26	-6985017.06%
Jul 26	-6985017.06%
Jul 26	-6985017.06%
Jul 26	-6985017.06%
Jul 26	-6985017.06%
Jun 26	-6985017.06%
Jun 26	-6985017.06%
Jun 26	-6985017.06%
Jun 26	-6985017.06%
May 26	-6985017.06%
May 26	-6985016.85%
May 26	-69850168.52%
May 26	-69850168.52%
May 26	-69850168.52%
Apr 26	-69850168.52%
Apr 26	-69850168.52%
Apr 26	-69850168.52%
Apr 26	-69850168.52%
Mar 26	-6985017.06%
Mar 26	-6985017.06%
Mar 26	-6985017.06%
Mar 26	-6985017.06%
Feb 26	-6985017.06%
Feb 26	-6985017.06%
Feb 26	-6985017.06%
Feb 26	-6985017.06%
Jan 26	-6985017.06%
Jan 26	-6985017.06%
Jan 26	-6985017.06%
Jan 26	-6985017.06%
Jan 26	-6985017.06%
Dec 25	-6985017.06%
Dec 25	-6985017.06%
Dec 25	-6985017.06%
Dec 25	-6985017.06%
Nov 25	-6985017.06%
Nov 25	-6985017.06%
Nov 25	-6985017.06%
Nov 25	-6985017.06%
Oct 25	-6985017.06%
Oct 25	-6985017.06%
Oct 25	-6985017.06%
Oct 25	-6985017.06%
Oct 25	-6985017.06%
Sep 25	-6985017.06%
Sep 25	-6985017.06%
Sep 25	-6985017.06%
Sep 25	-6985017.06%
Aug 25	-6985017.06%
Aug 25	-6985017.06%
Aug 25	-6985017.06%
Aug 25	-6985017.06%
Aug 25	-6985017.06%
Jul 25	-6985017.06%
Jul 25	-6985017.06%
Jul 25	-6985017.06%
Jul 25	-6985017.06%
Jun 25	-6985017.06%
Jun 25	-6985017.06%
Jun 25	-6985017.06%
Jun 25	-6985017.06%
May 25	-6985017.06%
May 25	-6985017.06%
May 25	-6985017.06%
May 25	-6985017.06%
May 25	-6985017.06%
Apr 25	-6985017.06%
Apr 25	-6985017.06%
Apr 25	-6985017.06%
Apr 25	-6985017.06%
Mar 25	-6985017.06%
Mar 25	-6985017.06%
Mar 25	-6985017.06%
Mar 25	-6985017.06%
Feb 25	-6985017.06%
Feb 25	-6985017.06%
Feb 25	-6985017.06%
Feb 25	-6985017.06%
Jan 25	-6985017.06%
Jan 25	-6985017.06%
Jan 25	-6985017.06%
Jan 25	-6985017.06%
Jan 25	-6985017.06%
Dec 24	-6985017.06%
Dec 24	-6985017.06%
Dec 24	-6985017.06%
Dec 24	-6985017.06%
Nov 24	-6985017.06%
Nov 24	-6985017.06%
Nov 24	-6985017.06%
Nov 24	-6985017.06%
Nov 24	-6985017.06%
Oct 24	-6985017.06%
Oct 24	-6985017.06%

Price to Sales

PARD Price to Sales by quarter
Period	Price to Sales
Mar 07	2954.28
Mar 07	2886.91
Mar 07	2902.45
Mar 07	3032.03
Mar 07	3006.11
Feb 07	3166.79
Feb 07	3140.87
Feb 07	3125.32
Feb 07	3068.31
Jan 07	2793.61
Jan 07	2653.67
Jan 07	2669.22
Jan 07	2446.35
Dec 06	2591.48
Dec 06	1868.57
Dec 06	2071.98
Dec 06	2192.64
Dec 06	2478.79
Nov 06	2389.15
Nov 06	2664.95
Nov 06	2275.38
Nov 06	1447.97
Oct 06	1482.44
Oct 06	1444.52
Oct 06	1237.67
Oct 06	1158.72
Sep 06	1206.64
Sep 06	326.1
Sep 06	308.93
Sep 06	354.7
Sep 06	389.03
Aug 06	377.59
Aug 06	407.91
Aug 06	286.05
Aug 06	337.54
Jul 06	360.42
Jul 06	457.68
Jul 06	509.17
Jul 06	518.89
Jun 06	554.94
Jun 06	566.6
Jun 06	611.83
Jun 06	628.83
Jun 06	679.83
May 06	657.16
May 06	674.16
May 06	679.83
May 06	715.99
Apr 06	708.16
Apr 06	691.16
Apr 06	685.49
Apr 06	725.06
Mar 06	747.72
Mar 06	1642.25
Mar 06	1856.25
Mar 06	1913.38
Mar 06	1999.07
Feb 06	1913.38
Feb 06	2084.77
Feb 06	1870.53
Feb 06	1527.99
Jan 06	1070.95
Jan 06	1086.66
Jan 06	1199.49
Jan 06	1270.9
Dec 05	1070.95
Dec 05	798.68
Dec 05	836.72
Dec 05	893.78
Dec 05	922.31
Nov 05	941.32
Nov 05	998.38
Nov 05	1197.93
Nov 05	1064.95
Oct 05	903.29
Oct 05	789.17
Oct 05	836.72
Oct 05	846.23
Sep 05	874.76
Sep 05	16.36
Sep 05	16.05
Sep 05	15.28
Sep 05	14.66
Aug 05	15.43
Aug 05	12.81
Aug 05	16.05
Aug 05	14.97
Jul 05	10.19
Jul 05	10.34
Jul 05	10.65
Jul 05	12.19
Jul 05	9.57
Jun 05	5.64
Jun 05	5.72
Jun 05	4.65
Jun 05	4.27
May 05	3.66
May 05	3.66
May 05	3.58
May 05	5.03

EV/EBITDA

PARD EV/EBITDA by quarter
Period	EV/EBITDA
Mar 04	6.74
Mar 04	5.71
Mar 04	5.59
Mar 04	6.99
Feb 04	6.95
Feb 04	9.03
Feb 04	9.12
Feb 04	7.63
Jan 04	7.56
Jan 04	7.74
Jan 04	7.88
Jan 04	6.99
Jan 04	6.41

Price/Operating Cashflow

PARD Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Mar 04	9.69
Mar 04	8.72
Mar 04	8.61
Mar 04	9.93
Feb 04	9.89
Feb 04	11.85
Feb 04	11.94
Feb 04	10.53
Jan 04	10.46
Jan 04	10.64
Jan 04	10.77
Jan 04	9.93
Jan 04	9.38
Dec 03	31.91
Dec 03	32.58
Dec 03	36.64
Dec 03	36.05
Nov 03	31.91
Nov 03	34.94
Nov 03	38.49
Nov 03	44.77
Oct 03	39
Oct 03	37.08
Oct 03	39.6
Oct 03	34.72
Oct 03	37.83

Price to Book

PARD Price to Book by quarter
Period	Price to Book
Sep 26	0
Sep 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jun 26	0
Jun 26	0
Jun 26	0
Jun 26	0
May 26	0
May 26	0
May 26	0
May 26	0
May 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Dec 25	0
Dec 25	0
Dec 25	0
Dec 25	0
Nov 25	0
Nov 25	0
Nov 25	0
Nov 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jun 25	0
Jun 25	0
Jun 25	0
Jun 25	0
May 25	0
May 25	0
May 25	0
May 25	0
May 25	0
Apr 25	0
Apr 25	0
Apr 25	0
Apr 25	0
Mar 25	0
Mar 25	0
Mar 25	0
Mar 25	0
Feb 25	0
Feb 25	0
Feb 25	0
Feb 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Dec 24	0
Dec 24	0
Dec 24	0
Dec 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Oct 24	0
Oct 24	0

No video analysis for this stock yet. Request one from our team.

AI Analysis

Poniard Pharmaceuticals, Inc.

Video analysis: PARD

Similar companies